NNPA NEWSWIRE — With the most recent collaboration between Pfizer Rare Disease and the Black Press, the organizations embarked on a mission to educate and raise awareness to transthyretin amyloid cardiomyopathy – or ATTR-CM. “ATTR-CM is a rare, life-threatening, underrecognized, and underdiagnosed
